Trump Cuts Ozempic, Wegovy Drug Prices
President Donald J. Trump announced groundbreaking agreements with pharmaceutical giants Eli Lilly and Novo Nordisk on November 6, 2025, to dramatically lower the cost of popular drugs like Ozempic and Wegovy for American patients, aiming for a $350 price point through the new "TrumpRx" program. This initiative seeks to align U.S. prescription drug prices with those in other developed nations by reviving the "Most-Favored-Nation" pricing concept and includes commitments to boost domestic manufacturing.